Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 7,513 articles

Articles by Daniel Marsh

Transocean and Valaris Shares Rise as Merger Spread Narrows to 2.25%
Markets

Transocean and Valaris Shares Rise as Merger Spread Narrows to 2.25%

Transocean (RIG) gained 1.24% to $5.305, while Valaris (VAL) rose 1.18% to $79.00, with the merger spread narrowing to 2.25% as the companies await regulatory clearance.

RIG VAL NE SDRL USO
Coeur Mining Market Cap Ties Pan American Silver Ahead of Key Cash Flow Report
Markets

Coeur Mining Market Cap Ties Pan American Silver Ahead of Key Cash Flow Report

Coeur Mining's market cap edges past Pan American Silver as investors await Q2 results on August 5 to assess cash flow from recently acquired mines.

CDE PAAS HL GLD SLV
Kalshi Midterm Hub Reveals Divergent House and Senate Odds
Analysis

Kalshi Midterm Hub Reveals Divergent House and Senate Odds

Kalshi's midterm hub highlights a sharp contrast: Democrats are heavily favored to win the House, but Senate control remains a tight race.

Dow Rises 142 Points; Two Stocks Drive Nearly 70% of Gain
Markets

Dow Rises 142 Points; Two Stocks Drive Nearly 70% of Gain

The Dow Jones Industrial Average climbed 142 points by midday Wednesday, with Caterpillar and Goldman Sachs accounting for nearly 70% of the gain.

CAT GS JNJ NVDA HON MSFT CRM AMZN CVX GOOGL TSLA
U.S. Stocks Hold Steady as Energy Surge Offsets Small-Cap Weakness
Markets

U.S. Stocks Hold Steady as Energy Surge Offsets Small-Cap Weakness

U.S. equities were little changed at midday Wednesday, with energy shares surging on higher oil prices while small caps lagged, as investors awaited earnings from Alphabet and Tesla.

GOOGL TSLA T SMCI XLE IWM SPY QQQ DIA
Mentari's $200M Private Placement Boosts InMed Merger Funding
Markets

Mentari's $200M Private Placement Boosts InMed Merger Funding

InMed Pharmaceuticals (INM) shares rose 21% after Mentari Therapeutics revealed a $200M private placement, boosting total merger financing to $490M.

INM XBI
Zhongchao Stock Surges 456% in Trading Frenzy, Volume 57 Times Float
Markets

Zhongchao Stock Surges 456% in Trading Frenzy, Volume 57 Times Float

Zhongchao Inc. (ZCMD) stock rocketed 456% in heavy trading, with volume reaching 57 times its public float amid multiple trading halts.

ZCMD
Micron Surges 12% as AI-Driven Memory Pricing Powers Rally
Markets

Micron Surges 12% as AI-Driven Memory Pricing Powers Rally

Micron shares surged 12% as AI-driven memory prices fueled a rally, lifting market cap by $119B. Q3 revenue hit $41.46B with gross margins at 85%.

MU GOOGL SNDK WDC BAC
IREN Surges 26% on AI Deals Easing GPU Financing
Markets

IREN Surges 26% on AI Deals Easing GPU Financing

IREN Limited (NASDAQ:IREN) surged 26% as AI collaborations eased GPU capital requirements, with the company raising its AI cloud annualized run-rate revenue target to over $4 billion.

IREN MSFT GS HUT CRWV NBIS
Lakewood-Amedex Surges 143% on Nu-3 Update, Volume Explodes
Markets

Lakewood-Amedex Surges 143% on Nu-3 Update, Volume Explodes

Lakewood-Amedex shares jumped 143.5% on heavy volume after providing an update on its Nu-3 antibiotic program, though no new patient data was disclosed.

XBI
SK hynix Accelerates AI Packaging Spending After Stock Reverses Early Gains
Markets

SK hynix Accelerates AI Packaging Spending After Stock Reverses Early Gains

SK hynix is speeding up AI packaging investment at its Cheongju P&T7 facility, approving 7.0931 trillion won, as shares closed lower after an early 9% rally. The move reflects rising capital spending on packaging alongside wafer production.

INTC GOOGL
Angelini Completes $4.1B Catalyst Buyout, Delists From Nasdaq
Markets

Angelini Completes $4.1B Catalyst Buyout, Delists From Nasdaq

Angelini Pharma has finalized its $4.1 billion all-cash acquisition of Catalyst Pharmaceuticals, delisting the stock from Nasdaq. The deal reflects an enterprise value of about 5.1 times projected 2026 revenue.

CPRX XBI